MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Psoriasis: Treatment and Pathogenesis
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,393 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,393 works in the cohort · of 4,299,418page 7 of 48

Labels cover 8 of 2,393 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,393 of 2,393 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate‐to‐severe plaque psoriasis and non‐pustular palmoplantar involvement: results from three phase 3 trials (<scp>UNCOVER</scp>‐1, <scp>UNCOVER</scp>‐2 and <scp>UNCOVER</scp>‐3)
Alan Menter, Richard B. Warren, Richard G. Langley, Joseph F. Merola, Lisa Kerr, Ellen B. Dennehy +4 more
2017· article· en· Journal of the European Academy of Dermatology and Venereology· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrowconsensus · none
74
citations
affunlabeled
Safety results from a pooled analysis of randomized, controlled phase II and III clinical trials and interim data from an open‐label extension trial of the interleukin‐12/23 monoclonal antibody, briakinumab, in moderate to severe psoriasis
Richard G. Langley, Kim Papp, Alice B. Gottlieb, Gerald G. Krueger, Kenneth B. Gordon, David A. Williams +3 more
2012· article· en· Journal of the European Academy of Dermatology and Venereology· Immunology and Microbiology
distilled prediction:candidate · noneconsensus · none
69
citations
affunlabeled
Diagnosis of Generalized Pustular Psoriasis
Hideki Fujita, Melinda Gooderham, Ricardo Romiti
2022· review· en· American Journal of Clinical Dermatology· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
68
citations
affaboutunlabeled
Economic burden of moderate to severe plaque psoriasis in Canada
Adrian R. Levy, Alison Davie, Nicole C. Brazier, Farah Jivraj, Lorne Albrecht, David Gratton +1 more
2012· article· en· International Journal of Dermatology· Immunology and Microbiology
distilled prediction:candidate · noneconsensus · none
64
citations
afffundunlabeled
Promising New Treatments for Psoriasis
Sarah Dubois Declercq, Roxane Pouliot
2013· review· en· The Scientific World JOURNAL· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+sts+insufficient_payloadconsensus · insufficient_payload
63
citations
affunlabeled
Etanercept in the treatment of palmoplantar pustulosis.
Robert Bissonnette, Yves Poulin, Chantal Bolduc, Catherine Maari, N Provost, Jerry Syrotuik +2 more
2008· article· en· PubMed· Immunology and Microbiology
distilled prediction:candidate · noneconsensus · none
63
citations

How this was built: Screen · Findings · About